ABCB1 and cancer: The expression of P-glycoprotein (P-gp) is inhibited, the production of ATP is reduced, the energy generated by ATP hydrolysis is reduced, and the excretion of drugs from cancer cells is reduced, thereby achieving the purpose of overcoming cancer drug resistance (Xiao et al., 2022).